Henan Lingrui Pharmaceutical Co., Ltd.: A Snapshot of Recent Developments and Market Performance

Henan Lingrui Pharmaceutical Co., Ltd., a prominent player in the health care sector, specializes in the manufacturing and marketing of Chinese medicines, including ointments, electuaries, tablets, and capsules. Based in Henan, China, the company is listed on the Shanghai Stock Exchange and trades under the currency CNH.

Recent Developments

As of the latest updates, Henan Lingrui Pharmaceutical has not issued any new announcements. However, the company’s most recent significant development occurred on November 6, 2024, when it successfully obtained a drug registration certificate. This achievement underscores the company’s ongoing efforts to expand its product offerings and regulatory compliance.

Market Performance

Over the past year, Henan Lingrui Pharmaceutical’s stock price has experienced fluctuations, ranging from a low of 18.49 CNH to a high of 27.26 CNH. As of April 29, 2025, the closing price was recorded at 22.85 CNH. The company’s valuation metrics, including a price-to-earnings ratio of 17.2 and a price-to-book ratio of 3.91, provide insights into its market standing.

Financial Overview

Henan Lingrui Pharmaceutical boasts a market capitalization of 12,960,000,000 CNH. The company’s financial health and market performance are critical indicators for investors and stakeholders in the pharmaceutical sector.

For more information, interested parties can visit the company’s official website at www.lingrui.com .

This article provides a concise overview of Henan Lingrui Pharmaceutical Co., Ltd.’s recent developments and market performance, based on the latest available data.